Latest Logistics News

Page 95 of 103
Reedy Lagoon Corporation reports promising soil sampling results at its Burracoppin Gold project while seeking partners for its iron venture amid challenging market conditions.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Northern Minerals reports a 15% increase in its Wolverine Deposit resource and secures $28 million in funding, advancing its Browns Range heavy rare earths project amid ongoing feasibility studies.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Tartana Minerals reports robust copper sulphate sales and completes a significant acquisition, positioning itself as a leading explorer and developer in Far North Queensland.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Akora Resources reports strong progress at its Bekisopa Iron Ore Project in Madagascar, highlighted by successful drilling results, completion of key technical studies, and official support from the Malagasy government. The company is on track to deliver a Pre-Feasibility Study by Q1 2025, aiming to produce high-grade direct shipping ore for steelmakers focused on decarbonisation.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Diatreme Resources has made significant strides in its silica sand ventures, signing a non-binding offtake MOU with Mitsui & Co and enhancing its leadership team. The company also reports strong cash reserves and ongoing environmental and community engagement efforts.
Maxwell Dee
Maxwell Dee
31 Jan 2025
DMC Mining Limited moves closer to ASX re-admission as Guinea reopens its cadastral licensing system, enabling imminent exploration licenses for key projects. The company also strengthens its leadership team and secures additional financing to support upcoming operations.
Maxwell Dee
Maxwell Dee
31 Jan 2025
Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.
Ada Torres
Ada Torres
31 Jan 2025
Mesoblast Limited is set to launch Ryoncil®, the first FDA-approved MSC therapy for pediatric steroid-refractory acute graft-versus-host disease, backed by a recent $160 million financing that strengthens its commercial and clinical development efforts.
Ada Torres
Ada Torres
31 Jan 2025
Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.
Ada Torres
Ada Torres
31 Jan 2025
Botanix Pharmaceuticals has initiated the commercial rollout of Sofdra, its FDA-approved treatment for primary axillary hyperhidrosis, with first prescriptions dispensed and a fully trained sales force deployed. The company anticipates meaningful revenue growth starting in the first quarter of 2025, backed by strong payer contracts and a robust cash position.
Victor Sage
Victor Sage
31 Jan 2025
QEM Limited has marked significant progress in its Julia Creek Vanadium and Energy Project, securing key government approvals and raising $2.76 million to advance development and environmental studies.
Maxwell Dee
Maxwell Dee
31 Jan 2025
TerraCom Limited reported resilient coal sales of 1.6 million tonnes for the December quarter despite weather disruptions, while advancing its Moorlands Thermal Coal Project and maintaining a fully franked dividend.
Maxwell Dee
Maxwell Dee
31 Jan 2025